Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 4 | 4 | 4 | 4 |
Avg. Estimate | -0.16 | -0.16 | -0.62 | -0.25 |
Low estimate | -0.17 | -0.2 | -0.75 | -0.86 |
High estimate | -0.15 | -0.13 | -0.46 | 0.08 |
Year ago EPS | -0.17 | -0.13 | -0.58 | -0.62 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 4 | 4 | 3 | 4 |
Avg. Estimate | N/A | N/A | N/A | 28.31M |
Low estimate | N/A | N/A | N/A | N/A |
High estimate | N/A | N/A | N/A | 56.86M |
Year ago sales | N/A | N/A | N/A | N/A |
Sales growth (year/est) | N/A | N/A | N/A | N/A |
Earnings history | 30/03/2023 | 29/06/2023 | 29/09/2023 | 30/12/2023 |
---|---|---|---|---|
Est. EPS | -0.17 | -0.18 | -0.14 | -0.15 |
Actual EPS | -0.17 | -0.13 | -0.14 | -0.14 |
Difference | 0 | 0.05 | 0 | 0.01 |
Surprise % | 0.00% | 27.80% | 0.00% | 6.70% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Current estimate | -0.16 | -0.16 | -0.62 | -0.25 |
7 days ago | -0.15 | -0.14 | -0.61 | -0.45 |
30 days ago | -0.15 | -0.14 | -0.61 | -0.45 |
60 days ago | -0.15 | -0.13 | -0.63 | -0.23 |
90 days ago | -0.15 | -0.13 | -0.63 | -0.23 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Up last 7 days | N/A | 1 | 3 | 2 |
Up last 30 days | N/A | 1 | 3 | 2 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | 2 | 2 | 1 | N/A |
Growth estimates | GLYC | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | 5.90% | N/A | N/A | N/A |
Next qtr. | -23.10% | N/A | N/A | N/A |
Current year | -6.90% | N/A | N/A | N/A |
Next year | 59.70% | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |